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Abstract: Background. Total laryngectomy following radia-
tion therapy or concurrent chemoradiation therapy is asso-
ciated with unacceptably high complication rates because
of wound healing difficulties. With an ever increasing reliance
on organ preservation protocols as primary treatment for
advanced laryngeal cancer, the surgeon must develop techni-
ques to minimize postoperative complications in salvage lar-
yngectomy surgery. We have developed an approach using
free tissue transfer in an effort to improve tissue vascularity,
reinforce the pharyngeal suture line, and minimize complica-
tions in this difficult patient population. The purpose of this
study was to outline our technique and determine the effec-
tiveness of this new approach.
Methods. We conducted a retrospective review of a pro-
spective cohort and compared it with a historical group (surgical
patients of Radiation Therapy Oncology Group (RTOG)-91-11
trial). Eligibility criteria for this study included patients under-
going salvage total laryngectomy following failed attempts at
organ preservation with either high-dose radiotherapy or concur-
rent chemo/radiation therapy regimen. Patients were excluded if
the surgical defect required a skin paddle for pharyngeal clo-
sure. The prospective cohort consisted of 14 consecutive
patients (10 males, 4 females; mean age, 58 years) who under-
went free tissue reinforcement of the pharyngeal suture line fol-
lowing total laryngectomy. The historical comparison group con-
sisted of 27 patients in the concomitant chemoradiotherapy arm
of the RTOG-91-11 trial who met the same eligibility criteria (26
males, 1 female; mean age, 57 years) but did not undergo free
tissue transfer or other form of suture line reinforcement. Mini-
mum follow-up in both groups was 12 months.
Results. The overall pharyngocutaneous fistula rate was
similar between groups—4/14 (29%) in the flap group, com-
pared with 8/27 (30%) in the RTOG-91-11 group. There were
no major wound complications in the flap group, compared
with 4 (4/27, 14.8%) in the RTOG-91-11 group. There were no
major fistulas in the flap group, compared with 3/27 (11.1%) in
the RTOG-91-11 group. The rate of pharyngeal stricture requir-
ing dilation was 6/14 (42%) in the flap group, compared with 7/
27 (25.9%) in the RTOG-91-11 group. In our patients, the rate of
tracheoesophageal speech was 14/14 (100%), and complete
oral intake was achieved in 13/14 (93%) patients. Voice-Related
Quality of Life Measure (V-RQOL) and Performance Status Scale
for Head and Neck Cancer Patients (PSS-HN) scores suggest
that speech and swallowing functions are reasonable following
free flap reinforcement.
Conclusions. Free vascularized tissue reinforcement of pri-
mary pharyngeal closure in salvage laryngectomy following
failed organ preservation is effective in preventing major wound
complications but did not reduce the overall fistula rate. Fistulas
that developed following this technique were relatively small, did
not result in exposed major vessels, and were effectively treated
with outpatient wound care rather than readmission to the hospi-
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Salvage surgery after intensive combined chemo-
radiation treatment is associated with high com-
plication rates because of wound healing prob-
lems. Pharyngocutaneous fistula is one of the most
common wound healing complications following
laryngectomy. Numerous risk factors, including
radiotherapy,1–4 nutrition, postoperative hemoglo-
bin,1,3 diabetes,1 liver disease,1 and stage,5 for fis-
tula development have been identified in various
retrospective studies. With the advent of organ
preservation therapy for advanced head and neck
cancer, the use of combined chemotherapy and
radiation therapy has become increasingly fre-
quent. A recent prospective randomized trial sup-
ports the role of combined chemoradiotherapy for
treatment of advanced laryngeal cancer.6 How-
ever, salvage laryngectomy in a setting of previous
chemoradiotherapy is associated with high rates
of wound complications, ranging from 59%7 to
77%.8 The toxic effects of radiation in conjunction
with chemotherapeutic agents on normal tissues
are well established.9,10 Microscopically, these
effects are manifested by obliterative endarteritis
and fibrosis.11 Therefore, methods to improve tis-
sue vascularity and healing should increase surgi-
cal success rates. Since November 1999, we have
used free vascularized tissue to reinforce pharyn-
geal closures (pharyngeal interposition graft
[PIG]) in salvage laryngectomy patients in a set-
ting of previous chemoradiation. The purpose of
this study was to determine whether PIG affects
the incidence of wound complications in salvage
laryngectomy patients following organ preserva-
tion therapy for advanced laryngeal carcinoma.
PATIENTS AND METHODS
Design. This was a retrospective review of a pro-
spective cohort (PIG group) and comparison with a
historical group (surgical patients in arm 2 of Radi-
ation Therapy Oncology Group (RTOG)-91-11).
Patients. We compared 2 groups of patients—a
prospective cohort (PIG Group) and a cohort
of historical controls (RTOG-91-11 Group). Data
for the PIG group were obtained from medical
records. Data for the RTOG-91-11 group were pre-
viously published and used with permission for
the purpose of comparison. Patient data for both
groups are summarized in Table 1. All patients
had aminimum follow-up of 12months.
Pharyngeal Interposition Graft Group. Patients
included in the study were those who were at high
risk for wound complications following total laryn-
gectomy. This study population included patients
with recurrent laryngeal carcinoma requiring sal-
vage total laryngectomy who were previously
treated with combined chemotherapy and radio-
therapy and patients with treatment-related tis-
sue damage (eg, chondroradionecrosis) severe
enough to warrant total laryngectomy in the ab-
sence of cancer. Patients were excluded if the sur-
gical defect required a skin paddle for pharyngeal
closure (ie, laryngopharyngectomy defects).
From September 1999 to February 2003, 18
consecutive patients underwent salvage laryngec-
tomy following previous organ preservation ther-
apy for advanced laryngeal carcinoma. All patients
were treated surgically at the University of Michi-
gan Health Center. Staff members in the Division
of Head and Neck Surgery performed all salvage
surgery and microvascular free tissue transfers.
Minimum follow-up was 12 months, and mean
follow-up was 30 months. Primary treatment con-
sisted of concomitant platinum-based chemother-
apy and radiotherapy in 12/14 (86%) patients, and
Table 1. Patient characteristics.
Patient demographics PIG group RTOG 91-11 group
Mean age, y 57.8 (40–73) 57.0 (40–70)
Sex, M:F 10:4 26:1
Stage
I 1 (7) 0
II 0 (0) 0
III 6 (43) 21 (77.8)
IV 7 (50) 6 (22.2)
Initial treatment
Chemoradiation 12 (86) 27 (100)













NED 11 (79) 19/27 (70)
DOD 0 (0) n.a.
AWD 3 (21) n.a.
Abbreviations: PIG, pharyngeal interposition graft; NED, no evidence of
disease; DOD, died of disease; AWD, alive with disease.
*Values in parentheses are percentages unless indicated otherwise.
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primary high-dose radiotherapy in 2/14 (14%)
patients. A chemoradiation regimen was delivered
as part of an induction and concurrent chemother-
apy and radiation therapy protocol at the Univer-
sity of Michigan Medical Center in 7/14 (50%) of
patients. Indications for surgical salvage included
recurrence in 12/14 (86%) patients and chondrora-
dionecrosis in 2/14 (14%) patients.
Surgical Technique. Surgical salvage consisted of
total laryngectomy. Bilateral neck dissection was
performed on patients with recurrent tumor. All
patients received primary tracheoesophageal punc-
ture. All pharyngeal defects were closed primarily
in a multilayered T configuration. Patients were
excluded if the defect required a skin paddle for
pharyngeal closure (ie, laryngopharyngectomy
defects). Fascial free tissue transfer was performed
to reinforce the primary pharyngeal closure in all
patients. The flap was held in position with tacking
sutures to prevertebral fascia on both sides of the
pharynx. The skin paddle was left on the PIG if the
native suprastomal neck skin appeared nonviable
after elevation.6 Reconstructive data are summar-
ized in Table 2. Patients were started on an oral
diet and the speech prosthesis was inserted on post-
operative day 28.
RTOG-91-11 Group. From 1992 to 2000, 27
patients who underwent salvage laryngectomy
with primary pharyngeal closure without vascu-
larized tissue reinforcement were enrolled in the
concomitant chemotherapy and radiotherapy arm
of the RTOG Trial 91-11. All patients initially
received concomitant chemotherapy consisting of
cisplatin (100 mg/m2) on days 1, 22, and 43 of
radiotherapy (RT), and RT consisting of 70 Gy
total dose in 2 Gy fractions delivered over 7 weeks.
This group also included 2 patients with chondror-
adionecrosis of the larynx or laryngeal dysfunc-
tion, similar to our flap group demographics.
Variables under Study. Awound complication was
defined as any deviation from the expected heal-
ing process. Wound complications were classified
as major or minor, as defined by Weber et al.7 A
major complication was defined as one that leads
to rehospitalization or death. A minor complica-
tion was defined as one that is self-limited, man-
aged with outpatient care, and does not require
hospitalization.
The secondary outcome variables were speech
and swallowing functions using validated quality
of life (QOL) instruments (Voice-Related Quality
of Life Measure, V-RQOL,12 and Performance Sta-
tus Scale for Head and Neck Cancer Patients,
PSS-HN13) and nutritional mode. Data were also
collected on presence of fluent tracheoesophageal
puncture (TEP) speech, time to oral intake, flap
complications, and donor site complications.
The V-RQOL is a 10-item self-administered
validated voice outcomes measure. Scores are
reported in 2 domains: social–emotional and phys-
ical functioning, and a total score. Two data sets
were used for comparison. The first consisted of
normative data from a published validation study
on a population of 21 facial cosmetic patients with-
out a known voice disorder.12 The second con-
sisted of a cohort of 12 patients who underwent
total laryngectomy without PIG. These normative
data were compared with V-RQOL scores obtained
from the PIG group. The instrument scores on a
scale from 0 to 100, and a higher score indicated
better function.
The Performance Status Scale is a 3-item ob-
server-rated validated speech and swallowing out-
comes measure.13 The 3 items include eating in
public (scale of 1–6), normalcy of diet (scale of
1–10), and understandability of speech (scale of 1–
5), where a higher score indicates better function.
Nutritional mode (categorical variable) was
assessed, and patients were assigned to one of
the following categories: (1) nothing by mouth,
(2) tube feeds, trial oral intake, (3) combined oral
and tube feeds, (4) nutritional supplements only
taken by mouth, (5) oral intake with nutritional
supplements, and (6) oral intake alone without
supplements.
Statistical Analysis. Comparisons of fistula rate
between the PIG group and the RTOG-91-11
group were made using a 2-tailed Fisher’s exact
Table 2. Reconstructive data.
No. (%)
Donor site
Radial forearm 9/14 (64)*
Anterolateral thigh 4 (29)
Lateral arm 1 (7)






Radial forearm—wound breakdown 2 (11.1)
*Values in parentheses are percentages.
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test. V-RQOL scores from the normal cohort as
well as standard laryngectomy group (without
PIG) were compared with V-RQOL scores in the
PIG group using a student’s 2-tailed t test. A 2-
tailed p value of .05 or less was considered to be
statistically significant.
Approval was obtained from the University of
Michigan Institutional Review Board (IRB Ap-
proval no. 2002-0459).
RESULTS
Wound Complications. Table 3 summarizes the
wound complications. Overall, pharyngocutanous
fistulas occurred in 4/14 (29%) patients in the free
flap group and 8/27 (30%) patients in the RTOG-
91-11 group. There were 3 major fistulas
(requiring hospitalization, reoperation, or result-
ing in death) in the RTOG-91-11 group, compared
with 0 in the PIG group, but this was not statisti-
cally significant (p ¼ .264). The rate of major
wound complications was higher in the RTOG-91-
11 group (14.8%), compared with that in the PIG
group (0%), but was not statistically significant (p
¼ .173).
Speech and Swallowing Functions. V-RQOL scores
were obtained in 13/14 (93%) patients. One
patient was excludedwho had a stomal recurrence
prior to survey administration. The patients with
a PIG had a total score of 66.5, whereas patients
who had a total laryngectomy without a PIG had a
total score of 65.8. This difference was not clini-
cally significant, which suggests that a PIG is nei-
ther an advantage nor a disadvantage in terms of
voice-related QOL. The control group of \normal"
patients had a total score of 98.0, which, as
expected, was statistically significant (p < .001).
Subscales and scores are shown in Table 4.
All 14 patients were alive and were communi-
cating fluently with a tracheoesophageal voice
prosthesis.
Performance Status Scale scores were ob-
tained in all patients. All patients supported their
nutritional needs exclusively with oral intake.
The mean time to oral intake was 40 days. With
respect to nutritional mode, 9/14 (64%) patients
were eating per orumwith no need for oral supple-
ments, 4/14 (29%) patients were eating per orum
but also required oral supplements, and 1/14 (7%)
patients required enteric supplementation.
DISCUSSION
This study suggests that, although PIG did not
alter the pharyngocutaneous fistula rate, major
wound complications were reduced. Wound com-
plications in patients undergoing PIG were effec-
tively treated with outpatient wound care rather
than major salvage flap procedures in the operat-
ing room. This result suggests that free vascular-
ized tissue reinforcement of primary pharyngeal
closure in this patient population may be benefi-
cial in preventing surgical intervention for phar-
yngocutaneous fistula. In other words, PIG may
\convert" major wound complications to minor
wound complications. This finding, if further sub-
stantiated by prospective data, would be clini-
cally important because of decreased patient mor-
bidity and mortality and savings to the health-
care system. Moreover, given the high rates of
tracheoesophageal speech and complete oral in-
take, PIG does not seem to adversely affect
speech and swallowing.
Patients who may benefit from PIG are those
at high risk for wound complications. These in-
clude, but are not limited to, the following:
(1) patients with recurrent laryngeal carcinoma
requiring salvage total laryngectomy who were
previously treated with combined chemotherapy
and radiotherapy, and (2) patients with treat-
ment-related tissue damage (eg, chondroradionec-
rosis) severe enough to warrant total laryngec-
tomy in the absence of cancer. A similar paper
has shown that free tissue reconstruction of the





Pharyngocutaneous fistula 0 3 (11.1%)
Wound infection 1 (5.6%) 1 (3.7%)
Death 0 0
Minor complications
Wound dehiscence/infection 2 (11.1%) 9 (33.3%)
Pharyngocutaneous fistula 5 (27.8%) 5 (18.5%)




Pharyngeal stenosis requiring dilation
Total number 6 (33.3%) 7 (25.9%)
Mean number of dilations
per patient
3 (1–10) n.a.
Abbreviations: PIG, pharyngeal interposition graft; RTOG, Radiation
Therapy Oncology Group.
Major complication—one that leads to rehospitalization or death. Minor
complication—one that is self-limited, managed with outpatient care,
and does not require hospitalization.
*The patient listed as having a fistula for 134 days actually had an inter-
mittent fistula, draining occasionally prior to healing.
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hypopharynx following chemoradiation results in
lower rates of wound complications.14 In total lar-
yngectomy patients, wherein primary pharyngeal
closure is possible, the pectoralis major myofascial
flap has been shown to result in a pharyngocuta-
neous fistula rate of less than 1%.15 In this retro-
spective study, however, only 26% of patients had
a history of prior radiation, and it is not known
whether any patients had previous chemoradio-
therapy. Nevertheless, the positive impact on
wound healing should be achieved by bringing
unirradiated tissue with good blood supply, from
any source, regional or distant. Our rationale for
using free tissue transfer is related to the follow-
ing factors: (1) pectoralis myofascial flaps result
in significant additional shoulder morbidity, par-
ticularly in patients undergoing ipsilateral neck
dissection; (2) the pectoralis muscle may impair
postoperative speech fluency because of alteration
of the shape of the tracheostoma; and (3) the bulk
of the pectoralis flap often makes it difficult to
close the skin incision in a tension-free manner,
making suprastomal skin necrosis more likely.
Preoperative radiotherapy has been identified
in several studies as a significant risk factor for
the development of pharyngocutaneous fistula fol-
lowing laryngectomy.1,3,4 Other studies examine
heterogeneous populations undergoing a variety
of surgeries, including surgery for the primary tu-
mor (ie, laryngectomy, laryngopharyngectomy,
composite resection) and surgery for nodal disease
(ie, neck dissection).16,17 Chemoradiation in these
studies has been found to be associated with high
complication rates (35–38%) but cannot be ex-
trapolated to a uniform population. We sought to
clearly define the utility of vascularized tissue in
patients with a specific defect in a high-risk
patient population. The quality of a study such as
this one would be improved by introducing a com-
parison group with primary closure alone and
evaluating the effect of a pharyngeal bypass tube.
Although speech results in the study popula-
tion were found to be inferior to normative data
from normal control patients, they were no differ-
ent from data obtained from patients who under-
went standard laryngectomy (without PIG). Fur-
thermore, the overwhelming majority of patients
were communicating fluently with a tracheo-
esophageal voice prosthesis. It is important to
know that the PIG, which is an additional fascial
layer over the pharyngeal closure, does not im-
pede with the vibratory (pharyngoesophageal)
segment. Moreover, the rate of pharyngeal steno-
sis requiring dilation is not higher, and postopera-
tive swallowing function is satisfactory in the
study population, suggesting that the addition of
this fascial layer also does not adversely affect
swallowing function.
CONCLUSIONS
Free vascularized tissue reinforcement of primary
pharyngeal closure in salvage laryngectomy fol-
lowing chemoradiation is an effective technique to
prevent major wound complications, although it
does not alter the overall fistula rate. Patients
who develop a pharyngocutaneous fistula after a
PIG procedure tend to have relatively small fistu-
las without great vessel exposure and can be effec-
tively treated with outpatient wound care rather
than hospital readmission and imminent return
to the operating room. In other words, PIG may
\convert" major wound complications into minor
wound complications, thereby decreasing morbid-
ity, mortality, and cost. Speech and swallowing
results following this technique are comparable to
those following total laryngectomy alone. The
complexity and added cost of such surgery empha-
sizes the need to carefully identify those patients
likely to benefit from primary chemoradiation in
order to minimize the number of patients requir-
ing salvage surgery.
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